
|Articles|February 1, 1996
The American Journal of Managed Care
- February 1996
- Volume 2
- Issue 2
Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products
Advertisement
Articles in this issue
over 29 years ago
Adapting Pharmacy Services to the Needs of Managed Careover 29 years ago
Advanced Practice Nurses and Success of Organized Delivery Systemsover 29 years ago
Ethical Issues in Managed Careover 29 years ago
The Economics of Compliance in Managed Healthcare SettingsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
3
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
4
Persistent Barriers Keep Oral HIV PrEP Out of Reach for High-Risk Groups
5















































